View Filter All NewsPress Release Years All Years202120202019201820172016201520142013201220112010 Apply Press Release | October 19, 2021 Vertex to Present Long-Term Data Demonstrating Significant Benefits of Treatment With CFTR Modulators at North American Cystic Fibrosis Conference (NACFC) READ MORE Press Release | October 18, 2021 Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes READ MORE Press Release | September 13, 2021 Vertex to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 15th READ MORE Press Release | August 26, 2021 Vertex Announces Publication in The New England Journal of Medicine of Phase 3 Results for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People With Cystic Fibrosis READ MORE Pagination Current page 1 Page 2 Page 3 Next page Next
